Shane R Stecklein - Publications

Affiliations: 
The University of Kansas Cancer Center 
Area:
Breast Cancer, Lymphoma, Radiation Biology

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, et al. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Molecular Oncology. PMID 34342930 DOI: 10.1002/1878-0261.13074  1
2021 Sharma P, Abramson VG, O'Dea AP, Nye L, Mayer IA, Pathak HB, Hoffmann M, Stecklein SR, Elia M, Lewis S, Scott J, De Jong JA, Wang YY, Yoder R, Schwensen K, et al. Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33602685 DOI: 10.1158/1078-0432.CCR-20-4879  1
2020 Stecklein SR, Sharma P. Last but not Least: Antibody-Drug Conjugates in Hormone Receptor-Positive Metastatic Breast Cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 33038485 DOI: 10.1016/j.annonc.2020.10.001  1
2020 Balema W, Larson R, Whye RV, Ye R, Ning J, Rahal O, Stecklein S, Krishnamurthy S, El-Zein R, Woodward W. Abstract P6-15-04: Modeling limited breastfeeding and diet on IBC like tumor progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P6-15-04  1
2019 Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. Practical Radiation Oncology. PMID 31132433 DOI: 10.1016/J.Prro.2019.05.011  1
2019 Stecklein SR, Shaitelman SF. In Reply to Mailhot et al. International Journal of Radiation Oncology, Biology, Physics. 103: 1281. PMID 30900563 DOI: 10.1016/J.Ijrobp.2018.11.062  1
2019 Stecklein SR, Bloom ES. Reply to the Letter to the Editor "Regarding: Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy". Practical Radiation Oncology. PMID 30709648 DOI: 10.1016/J.Prro.2018.10.011  0.01
2019 Villodre E, Larson R, Hu X, Stecklein S, Gomez K, Finetti P, Krishnamurthy S, Ivan C, Su X, Ueno N, Laere SV, Bertucci F, Tripathy D, Vivas-Mejía P, Woodward WA, et al. Abstract P2-01-03: Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-01-03  1
2019 Rahal O, Woodward WA, Stecklein SR, Wyhe RDV, Larson R. Microenviroment-mediated Induction of Protein Kinase C – zeta in Breast Inflammatory Carcinoma Cells as a Possible Mediator of Radioresistance. International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1000  1
2018 Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Kirsner SM, et al. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Practical Radiation Oncology. PMID 30125673 DOI: 10.1016/J.Prro.2018.08.003  1
2018 Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29928946 DOI: 10.1016/J.Ijrobp.2018.06.016  1
2018 Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecologic Oncology. PMID 29336837 DOI: 10.1016/J.Ygyno.2018.01.007  0.04
2018 Stecklein S, Babiera G, Bedrosian I, Shaitelman S, Ballo M, Tereffe W, Arzu I, Perkins G, Strom E, Reed V, Dvorak T, Smith B, Woodward W, Hoffman K, Schlembach P, et al. Abstract P2-11-12: Prospective comparison of late toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multi-lumen intracavitary brachytherapy Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P2-11-12  1
2018 Stecklein SR, Wolfe AR, Debeb BG, Larson RA, Woodward WA. Abstract 2397: Intracellular cholesterol regulates the DNA damage response in inflammatory breast cancer Cancer Research. 78: 2397-2397. DOI: 10.1158/1538-7445.Am2018-2397  1
2018 Stecklein SR, Rosso KJ, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiation Therapy Approach International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1588  1
2018 Colbert LE, Medrano AYD, Mikkelson MD, Previs R, Eifel PJ, Jhingran A, Ramondetta L, Futreal PA, Jazaeri A, Frumovitz M, Schmeler K, Hillman RT, Matthew G, Hutchinson DL, Ajami N, ... Stecklein SR, et al. Clonal Expansion of Antigen Specific T-Cells during Radiation Therapy for HPV Associated Cervical Cancers Is Regulated By the Vaginal Microbiome International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.145  0.01
2017 Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecologic Oncology. PMID 29089122 DOI: 10.1016/J.Ygyno.2017.10.017  0.01
2017 Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, Ueno NT, Brewster AM, Woodward WA. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. Journal of Cancer. 8: 1726-1732. PMID 28819368 DOI: 10.7150/Jca.20095  1
2017 Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery. Annals of Surgical Oncology. 24: 2981-2988. PMID 28766220 DOI: 10.1245/S10434-017-5952-X  1
2017 Stecklein SR, Park M, Liu DD, Valle JJ, Caudle AS, Mittendorf EA, Barcenas CH, Woodward WA, Valero V, Shaitelman SF. Impact of Regional Nodal Irradiation After Neoadjuvant Chemotherapy in Breast Cancer Patients With Cytologically Confirmed Axillary Lymph Node Metastases International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.704  1
2016 Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecologic Oncology. 143: 552-557. PMID 27645621 DOI: 10.1016/J.Ygyno.2016.09.011  0.01
2016 Stecklein SR, Shen X, Mitchell MP. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study. Clinical Breast Cancer. PMID 26943990 DOI: 10.1016/J.Clbc.2016.02.001  1
2016 Stecklein SR, Burzawa JK, Jhingran A, Klopp AH, Eifel PJ, Frumovitz M. Patterns of Failure and Survival in Neuroendocrine Carcinoma of the Cervix International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.1363  0.01
2015 Kumaraswamy E, Wendt KL, Augustine LA, Stecklein SR, Sibala EC, Li D, Gunewardena S, Jensen RA. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene. 34: 4333-46. PMID 25417703 DOI: 10.1038/Onc.2014.363  1
2015 Stecklein SR, Reddy J, Wolfe A, Lopez MS, Fouad TM, Debeb BG, Brewster AM, Ueno NT, Woodward WA. Lack of Breastfeeding History in Parous Women With Inflammatory Breast Cancer Predicts Locoregional Recurrence and Distant Metastasis International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.563  1
2014 Stecklein SR, Sharma P. Tumor homologous recombination deficiency assays: another step closer to clinical application? Breast Cancer Research : Bcr. 16: 409. PMID 25928813 DOI: 10.1186/S13058-014-0409-7  1
2014 Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11. PMID 25177489 DOI: 10.7243/2049-7962-3-2  1
2014 Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, et al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Research and Treatment. 145: 707-14. PMID 24807107 DOI: 10.1007/S10549-014-2980-0  1
2014 Paul A, Gunewardena S, Stecklein SR, Saha B, Parelkar N, Danley M, Rajendran G, Home P, Ray S, Jokar I, Vielhauer GA, Jensen RA, Tawfik O, Paul S. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis. Cell Death and Differentiation. 21: 1469-81. PMID 24786829 DOI: 10.1038/Cdd.2014.62  1
2014 Stecklein SR, Lee YC, Mitchell MP. Dosimetric Effects of Respiratory Motion and Interfraction Setup Variation on Internal Mammary Node Irradiation International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2426  1
2014 Stecklein SR, Jensen RA. Breast cancer stem cells Stem Cells and Human Diseases. 451-465. DOI: 10.1007/978-94-007-2801-1_20  1
2013 Stecklein S, Mitchell MP, Shen X. Utilization and Outcomes of Postmastectomy Radiation Therapy for Locally-Advanced Invasive Lobular Carcinoma: A SEER Study International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.639  1
2013 Stecklein S, Elsarraj H, Valdez K, Paul A, Behbod F. Breast cancer invasion and metastasis Experimental Metastasis: Modeling and Analysis. 27-56. DOI: 10.1007/978-94-007-7835-1_3  1
2012 Stecklein SR, Kumaraswamy E, Behbod F, Wang W, Chaguturu V, Harlan-Williams LM, Jensen RA. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation. Proceedings of the National Academy of Sciences of the United States of America. 109: 13650-5. PMID 22869732 DOI: 10.1073/Pnas.1203326109  1
2012 Stecklein SR, Jensen RA. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Translational Research : the Journal of Laboratory and Clinical Medicine. 160: 178-97. PMID 22683426 DOI: 10.1016/J.Trsl.2012.01.022  1
2012 Elsarraj HS, Stecklein SR, Valdez K, Behbod F. Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 17: 79-87. PMID 22350993 DOI: 10.1007/S10911-012-9240-X  1
2012 Stecklein SR, Jensen RA, Pal A. Genetic and epigenetic signatures of breast cancer subtypes. Frontiers in Bioscience (Elite Edition). 4: 934-49. PMID 22201926  1
2012 Bhalla K, Rao R, Sharma P, Gupta SD, Chauhan L, Stecklein S, Fiskus W. Abstract S3-7: Treatment with Histone Deacetylase Inhibitors Creates ‘BRCAness’ and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-S3-7  1
2012 Sharma P, Stecklein S, Kimler B, Klemp J, Khan Q, Fabian C, Tawfik O, Connor C, McGinness M, Mammen J, Jensen R. Abstract PD09-02: BRCA1 insufficiency is predictive of superior survival in patients with triple negative breast cancer treated with platinum based chemotherapy Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd09-02  1
2011 Sharma P, Kimler BF, Park YA, Stecklein SR, Khan QJ, Petroff BK, Tawfik OW, Jensen RA. Association of BRCA1 promoter methylation in triple-negative breast cancer (TNBC) with resistance to standard anthracyline-based adjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1123. PMID 28021523 DOI: 10.1200/Jco.2011.29.15_Suppl.1123  1
2011 Kumaraswamy E, Stecklein SR, Augustine LA, Jensen RA. Abstract 1188: BRCA1 regulates EGFR expression through microRNAs Cancer Research. 71: 1188-1188. DOI: 10.1158/1538-7445.Am2011-1188  1
2011 Jensen RA, Harlan-Williams LM, Wang W, Stecklein SR. Basic cancer biology and immunology Principles and Practice of Fertility Preservation. 35-48. DOI: 10.1017/CBO9780511921896.007  1
2010 Harlan-Williams LM, Overton JA, Stecklein SR, Wang W, Jensen RA. Abstract 757: Identification and characterization of small molecule activators of BRCA1 expression Cancer Research. 70: 757-757. DOI: 10.1158/1538-7445.Am10-757  1
2010 Stecklein SR, Harlan-Williams LM, Wang W, Eskew JD, Chaguturu V, Jensen RA. Abstract 1391: Inhibition of Hsp90 induces BRCA1 degradation and hypersensitivity to ionizing radiation Cancer Research. 70: 1391-1391. DOI: 10.1158/1538-7445.Am10-1391  1
Show low-probability matches.